Dr. Raed Al-Rajabi
Claim this profileUniversity of Kansas Cancer Center-Overland Park
Area of expertise
Liver Cancer
Raed Al-Rajabi has run 4 trials for Liver Cancer. Some of their research focus areas include:
Cancer
Raed Al-Rajabi has run 3 trials for Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of Kansas Cancer Center-Overland Park
University Of Kansas Cancer Center - North
Clinical Trials Raed Al-Rajabi is currently running
SynKIR-110
for Ovarian Cancer
This first-in-human (FIH) trial is designed to assess the safety, feasibility, and potential activity of a single intravenous (IV) dose of SynKIR-110 administered to subjects with mesothelin-expressing advanced ovarian cancer, mesothelioma, and cholangiocarcinoma.
Recruiting
1 award
Phase 1
7 criteria
Temozolomide + Tuvusertib
for Cancer
This trial tests a combination of two drugs, temozolomide and M1774, in patients with advanced cancer that has spread. Temozolomide damages cancer cell DNA, while M1774 blocks growth enzymes. The goal is to find a more effective treatment for these patients.
Recruiting
1 award
Phase 1 & 2
More about Raed Al-Rajabi
Clinical Trial Related
9 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Raed Al-Rajabi has experience with
- Durvalumab
- Nivolumab
- Ipilimumab
- Regorafenib
- Cabozantinib
- Irinotecan
Breakdown of trials Raed Al-Rajabi has run
Liver Cancer
Cancer
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Raed Al-Rajabi specialize in?
Raed Al-Rajabi focuses on Liver Cancer and Cancer. In particular, much of their work with Liver Cancer has involved PD-L1 positive patients, or patients who are Stage II.
Is Raed Al-Rajabi currently recruiting for clinical trials?
Yes, Raed Al-Rajabi is currently recruiting for 6 clinical trials in Overland Park Kansas. If you're interested in participating, you should apply.
Are there any treatments that Raed Al-Rajabi has studied deeply?
Yes, Raed Al-Rajabi has studied treatments such as Durvalumab, Nivolumab, Ipilimumab.
What is the best way to schedule an appointment with Raed Al-Rajabi?
Apply for one of the trials that Raed Al-Rajabi is conducting.
What is the office address of Raed Al-Rajabi?
The office of Raed Al-Rajabi is located at: University of Kansas Cancer Center-Overland Park, Overland Park, Kansas 66210 United States. This is the address for their practice at the University of Kansas Cancer Center-Overland Park.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.